Expression of programmed death-1 on lymphocytes in myeloma patients is lowered during lenalidomide maintenance

Haematologica. 2018 Mar;103(3):e126-e129. doi: 10.3324/haematol.2017.178947. Epub 2017 Nov 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Humans
  • Immunologic Factors
  • Lenalidomide / therapeutic use*
  • Lymphocytes / metabolism*
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / metabolism
  • Programmed Cell Death 1 Receptor / metabolism*

Substances

  • Immunologic Factors
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Lenalidomide